Guyana looks to send the associated gas from the Liza 1 and 2 fields to the shore, process it and use it for power generation ...

Doubts are growing over Guyana's pick of a little-known U.S. startup to craft and develop projects to monetize its vast ...

Guyana's ambitious plan to develop its natural gas reserves is at a standstill after selecting the U.S. startup Fulcrum LNG ...

Guyana's selection of Fulcrum LNG, an upstart U.S. company, to develop its natural gas resources is facing skepticism. With financing doubts and a lack of experience, the choice is now under scrutiny, ...

Doubts are growing over Guyana's pick of a little-known U.S. startup to craft and develop projects to monetize its vast ...

Fulcrum Therapeutics FULC, a clinical-stage company, is expected to report third-quarter 2024 results early next month. The Zacks Consensus Estimate for the to-be-reported quarter’s loss is ...

Doubts are growing over Guyana's pick of a little-known U.S. startup to craft and develop projects to monetize its vast untapped natural gas resources that could cost up to $30 billion. Year-old ...

CAMBRIDGE, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to ...

7 analysts have shared their evaluations of Fulcrum Therapeutics (NASDAQ:FULC) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a ...

Fulcrum Therapeutics ( (FULC)) has released its Q3 earnings. Here is a breakdown of the information Fulcrum Therapeutics presented to its investors. Fulcrum Therapeutics is a clinical-stage ...